An antibody constant region having reduced binding activity with Fcγ receptor as a result of modification of the amino acid sequence of the constant region of an antibody was researched for the purpose of drug development. As a result, a novel constant region sequence having reduced binding activity with Fcγ receptor compared with a conventional antibody constant region was discovered.